Hepion Pharmaceuticals (HEPA) Short Interest Ratio & Short Volume $0.04 +0.00 (+0.25%) As of 08/6/2025 03:39 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Hepion Pharmaceuticals Short Interest DataHepion Pharmaceuticals (HEPA) has a short interest of 16,200 shares. This marks a -56.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 216,185 shares to cover all short positions.Current Short Interest16,200 sharesPrevious Short Interest37,500 sharesChange Vs. Previous Month-56.80%Dollar Volume Sold Short$782.46Short Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares11,435,000 sharesPercentage of Shares Shorted0.14%Today's Trading Volume293,221 sharesAverage Trading Volume216,185 sharesToday's Volume Vs. Average136% Short Selling Hepion Pharmaceuticals? Sign up to receive the latest short interest report for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHEPA Short Interest Over TimeHEPA Days to Cover Over TimeHEPA Percentage of Float Shorted Over Time Hepion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202516,200 shares $782.46 -56.8%N/A0.1 $0.05 6/30/202537,500 shares $3 thousand +88.4%0.6%0.3 $0.08 6/15/202519,900 shares $1.39 thousand +42.1%0.3%0.1 $0.07 5/31/202514,000 shares $910.00 -87.4%0.2%0 $0.07 5/15/2025110,900 shares $14.03 thousand -75.3%N/A0 $0.13 4/30/2025448,200 shares $129.71 thousand -30.8%4.1%0.1 $0.29 4/15/2025647,400 shares $226.59 thousand +224.0%5.9%0.2 $0.35 3/31/2025199,800 shares $85.89 thousand +25.2%26.1%0.1 $0.43 3/15/2025159,600 shares $183.54 thousand -96.2%14.9%0.2 $1.15 2/28/20254,160,000 shares $524.16 thousand -12.4%39.4%0.2 $0.13 Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20254,750,000 shares $869.73 thousand +75.3%44.9%0.3 $0.18 1/31/20252,710,000 shares $486.45 thousand +1,180.7%25.5%0.2 $0.18 1/15/2025211,600 shares $90.50 thousand +774.4%3.0%0 $0.43 12/31/202424,200 shares $11.38 thousand -44.8%0.4%0.4 $0.47 12/15/202443,800 shares $25.84 thousand -7.2%0.6%1 $0.59 11/30/202447,200 shares $31.53 thousand -26.6%0.7%1.1 $0.67 11/15/202464,300 shares $43.72 thousand -2.1%0.9%1.6 $0.68 10/31/202465,700 shares $42.64 thousand +247.6%1.1%1.5 $0.65 10/15/202418,900 shares $10.76 thousand -24.7%0.3%0.4 $0.57 9/30/202425,100 shares $16.82 thousand -59.9%0.4%0.2 $0.67 9/15/202462,600 shares $46.32 thousand -17.3%1.1%0.4 $0.74 8/31/202475,700 shares $63.44 thousand -6.8%1.3%0.5 $0.84 8/15/202481,200 shares $54.79 thousand -29.5%1.4%0.5 $0.67 7/31/2024115,200 shares $90.18 thousand +852.1%2.0%0.7 $0.78 7/15/202412,100 shares $12.83 thousand -50.4%0.2%0.1 $1.06 6/30/202424,400 shares $24.89 thousand +58.4%0.5%0.7 $1.02 6/15/202415,400 shares $17.08 thousand -40.1%0.3%0.4 $1.11 5/31/202425,700 shares $32.38 thousand -21.7%0.5%0.6 $1.26 5/15/202432,800 shares $38.05 thousand -48.7%0.6%0.7 $1.16 4/30/202463,900 shares $87.22 thousand -0.2%1.2%0.9 $1.37 4/15/202464,000 shares $139.52 thousand +1.9%1.2%0.8 $2.18 3/31/202462,800 shares $156.37 thousand +11.0%1.5%0.8 $2.49 3/15/202456,600 shares $127.92 thousand -19.6%1.3%0.7 $2.26 2/29/202470,400 shares $209.09 thousand -11.0%1.6%0.8 $2.97 2/15/202479,100 shares $211.99 thousand +18.2%1.9%0.9 $2.68 1/31/202466,900 shares $127.11 thousand -17.7%1.6%0.9 $1.90 1/15/202481,300 shares $223.58 thousand -18.0%1.9%1.2 $2.75 12/31/202399,200 shares $321.41 thousand -18.5%2.3%1.5 $3.24 12/15/2023121,700 shares $484.37 thousand -61.6%2.8%1.9 $3.98 11/30/2023317,200 shares $1.02 million -4.4%7.4%5.7 $3.22Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher. 11/15/2023331,700 shares $959.01 thousand +15.0%7.8%6.8 $2.89 10/31/2023288,500 shares $1.35 million -22.8%6.9%8.8 $4.67 10/15/2023373,700 shares $1.72 million -11.4%9.9%12.3 $4.61 9/30/2023421,900 shares $2.11 million +10.5%11.2%15.7 $4.99 9/15/2023381,700 shares $2.00 million +24.9%10.1%13.3 $5.25 8/31/2023305,700 shares $2.28 million +3.1%8.0%8.9 $7.45 8/15/2023296,600 shares $2.07 million -8.9%7.7%0.8 $6.99 7/31/2023325,700 shares $2.59 million +2.4%8.6%0.9 $7.95 7/15/2023318,000 shares $3.18 million -1.8%8.4%0.9 $9.99 6/30/2023323,800 shares $3.40 million -11.1%8.5%0.9 $10.50 6/15/2023364,100 shares $4.21 million +52.9%9.6%1 $11.57 5/31/2023238,200 shares $2.29 million +237.4%6.3%0.7 $9.60 5/15/202370,600 shares $473.02 thousand +105.8%1.9%0.2 $6.70 4/30/2023685,900 shares $477.04 thousand +6.3%0.9%3.8 $0.70 4/15/2023645,100 shares $490.28 thousand -7.7%0.9%2.6 $0.76 3/31/2023698,800 shares $542.62 thousand -2.8%0.9%1 $0.78 3/15/2023719,000 shares $540.33 thousand +0.3%0.9%1 $0.75 2/28/2023716,600 shares $625.95 thousand -13.8%0.9%1 $0.87 2/15/2023831,100 shares $706.44 thousand -8.3%1.1%1.1 $0.85 1/31/2023905,900 shares $661.13 thousand -49.1%1.2%1.2 $0.73 1/15/20231,780,000 shares $1.65 million +221.0%2.3%2.5 $0.93 12/30/2022554,600 shares $166.55 thousand +0.3%0.7%1.7 $0.30 12/15/2022553,100 shares $182.52 thousand +3.2%0.7%2.6 $0.33 11/30/2022535,800 shares $195.67 thousand -2.5%0.7%2.9 $0.37 11/15/2022549,700 shares $241.81 thousand -5.4%0.7%3.2 $0.44 10/31/2022581,200 shares $309.49 thousand -9.9%0.8%3.9 $0.53 10/15/2022645,200 shares $296.73 thousand -6.6%0.9%4.7 $0.46 9/30/2022691,000 shares $349.09 thousand -6.3%0.9%4.9 $0.51 9/15/2022737,500 shares $441.03 thousand -9.5%1.0%5.1 $0.60 8/31/2022814,700 shares $556.20 thousand -15.3%1.1%5.2 $0.68 8/15/2022961,600 shares $712.83 thousand -12.6%1.3%5.9 $0.74 7/31/20221,100,000 shares $594 thousand +21.6%1.5%5.6 $0.54 7/15/2022904,700 shares $544.09 thousand -7.7%1.2%4.6 $0.60 6/30/2022980,300 shares $561.22 thousand -7.5%1.3%4.9 $0.57 6/15/20221,060,000 shares $717.62 thousand -7.0%1.4%4.6 $0.68 5/31/20221,140,000 shares $889.31 thousand -7.3%1.5%4.8 $0.78 5/15/20221,230,000 shares $852.39 thousand -14.6%1.6%4.1 $0.69 4/30/20221,440,000 shares $1.33 million -9.4%1.9%4.6 $0.93 4/15/20221,590,000 shares $1.67 million -7.0%2.1%4.3 $1.05 3/31/20221,710,000 shares $2.21 million +8.2%2.3%4.2 $1.29 3/15/20221,580,000 shares $1.69 million -0.6%2.1%3 $1.07 2/28/20221,590,000 shares $1.75 million -5.4%2.1%2.8 $1.10 2/15/20221,680,000 shares $1.71 million -10.2%2.2%2.7 $1.02 1/31/20221,870,000 shares $1.83 million +2.2%2.5%2.6 $0.98 1/15/20221,830,000 shares $2.12 million -6.2%2.4%2.4 $1.16 12/31/20211,950,000 shares $2.22 million +2.6%2.6%2.6 $1.14 12/15/20211,900,000 shares $2.30 million +15.2%2.5%2.4 $1.21 11/30/20211,650,000 shares $2.05 million -7.8%2.2%1.5 $1.24 11/15/20211,790,000 shares $2.63 million -1.1%2.4%1.5 $1.47 10/29/20211,810,000 shares $2.59 million -11.3%2.4%1.5 $1.43Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher. 10/15/20212,040,000 shares $3.10 million +17.9%2.7%1.6 $1.52 9/30/20211,730,000 shares $2.65 million -40.1%2.3%1.1 $1.53 9/15/20212,890,000 shares $4.60 million +61.5%3.8%1.7 $1.59 8/31/20211,790,000 shares $2.88 million -10.5%2.4%0.9 $1.61 8/13/20212,000,000 shares $2.94 million -14.5%2.6%1.1 $1.47 7/30/20212,340,000 shares $3.60 million -2.1%3.1%1.2 $1.54 7/15/20212,390,000 shares $3.80 million +64.8%3.1%1.1 $1.59 6/30/20211,450,000 shares $2.87 million -13.7%1.9%0.7 $1.98 6/15/20211,680,000 shares $3.70 million +27.3%2.2%0.8 $2.20 5/28/20211,320,000 shares $2.24 million +6.5%1.7%0.4 $1.70 5/14/20211,240,000 shares $1.93 million -32.6%N/A0.3 $1.56 4/30/20211,840,000 shares $3.28 million -20.7%N/A0.3 $1.78 4/15/20212,320,000 shares $4.08 million -22.9%N/A0.4 $1.76 3/31/20213,010,000 shares $5.36 million +57.6%N/A0.5 $1.78 3/15/20211,910,000 shares $4.66 million -26.5%N/A0.3 $2.44 2/26/20212,600,000 shares $5.10 million +273.3%N/A0.5 $1.96 2/12/2021696,500 shares $1.98 million +159.7%N/A0.1 $2.84 1/29/2021268,200 shares $549.81 thousand -6.8%N/A0.1 $2.05 1/15/2021287,600 shares $672.98 thousand -58.0%N/A0.1 $2.34 12/31/2020685,100 shares $1.61 million +236.7%N/A0.4 $2.35 12/15/2020203,500 shares $386.65 thousand -43.4%N/A0.1 $1.90 11/30/2020359,500 shares $607.56 thousand +9.7%N/A0.4 $1.69 11/15/2020327,600 shares $956.59 thousand +51.3%N/A1.5 $2.92 10/30/2020216,600 shares $723.44 thousand -39.7%N/A0.9 $3.34 10/15/2020359,400 shares $1.25 million -26.7%N/A0.9 $3.47 9/30/2020490,500 shares $1.53 million +4.1%N/A0.9 $3.11 9/15/2020471,000 shares $1.53 million -22.7%N/A0.3 $3.25 HEPA Short Interest - Frequently Asked Questions What is Hepion Pharmaceuticals' current short interest? Short interest is the volume of Hepion Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 16,200 shares of HEPA short. Learn More on Hepion Pharmaceuticals' current short interest. Is Hepion Pharmaceuticals' short interest increasing or decreasing? Hepion Pharmaceuticals saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 16,200 shares, a decrease of 56.8% from the previous total of 37,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hepion Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Hepion Pharmaceuticals: Vaccinex, Inc. (0.08%), Aditxt, Inc. (6.30%), Can-Fite BioPharma Ltd. (2.64%), Alzamend Neuro, Inc. (3.16%), Aptevo Therapeutics Inc. (5.41%), Entero Therapeutics, Inc. (14.61%), Jaguar Animal Health, Inc. (2.91%), Onconetix, Inc. (45.43%), Scinai Immunotherapeutics Ltd. Sponsored ADR (2.84%), Galera Therapeutics, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Hepion Pharmaceuticals stock? Short selling HEPA is an investing strategy that aims to generate trading profit from Hepion Pharmaceuticals as its price is falling. HEPA shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hepion Pharmaceuticals? A short squeeze for Hepion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HEPA, which in turn drives the price of the stock up even further. How often is Hepion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEPA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies VCNX Short Interest Data ADTX Short Interest Data CANF Short Interest Data ALZN Short Interest Data APVO Short Interest Data ENTO Short Interest Data JAGX Short Interest Data ONCO Short Interest Data SCNI Short Interest Data GRTX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HEPA) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HEPA Stock Alerts